Swiss biotech KetoSwiss bag €4.37M to develop treatment for migraine, related neurological disorders
Basel, Switzerland-based KetoSwiss, a biotechnology company, announced that it has secured $4.8M (approximately €4.37M) in a Pre-Series A round of funding from various investors.